{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:49:56Z","timestamp":1757623796537,"version":"3.44.0"},"reference-count":30,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The development of gender identity takes place under the influence of a complex interplay of social, psychological, and biological factors. Studies in individuals with disorders of sex development have suggested that exposure to androgens during fetal development and across the lifespan may contribute to a more masculine gender identity. We describe here an individual designated female at birth who presented with severe hyperandrogenism (total testosterone 337\u2005ng\/dL, 11.7\u2005nmol\/L) (reference range, 6-50\u2005ng\/dL [0.21-1.74\u2005nmol\/L]) and virilization secondary to polycystic ovarian syndrome in the setting of gender identity exploration. On presentation the patient endorsed a masculine gender identity, and after GnRH analog therapy reduced total testosterone to the cisgender female range, endorsed a feminine gender identity. This case adds to what is known about the possible range of androgen excess in polycystic ovarian syndrome and demonstrates the diagnosis and treatment of polycystic ovarian syndrome in a gender diverse adolescent.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf186","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:07:13Z","timestamp":1757408833000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Hyperandrogenism Secondary to Polycystic Ovarian Syndrome in a Gender-diverse Adolescent"],"prefix":"10.1210","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3553-8423","authenticated-orcid":false,"given":"Derek","family":"Schneider","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The Warren Alpert Medical School of Brown University , Providence, RI 02903 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Scully","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Warren Alpert Medical School of Brown University , Providence, RI 02903 ,","place":["USA"]},{"name":"Division of Pediatric Endocrinology and Diabetes, Hasbro Children's Brown University Health , Providence, RI 02903 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Bernardo","family":"Quintos","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Warren Alpert Medical School of Brown University , Providence, RI 02903 ,","place":["USA"]},{"name":"Division of Pediatric Endocrinology and Diabetes, Hasbro Children's Brown University Health , Providence, RI 02903 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5222-5787","authenticated-orcid":false,"given":"Kate","family":"Millington","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Warren Alpert Medical School of Brown University , Providence, RI 02903 ,","place":["USA"]},{"name":"Division of Pediatric Endocrinology and Diabetes, Hasbro Children's Brown University Health , Providence, RI 02903 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"issue":"2","key":"2025090905070948700_luaf186-B1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.yhbeh.2013.02.020","article-title":"Gender identity development in adolescence","volume":"64","author":"Steensma","year":"2013","journal-title":"Horm Behav"},{"issue":"4","key":"2025090905070948700_luaf186-B2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10508-005-4339-4","article-title":"Gender change in 46,XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency","volume":"34","author":"Cohen-Kettenis","year":"2005","journal-title":"Arch Sex Behav"},{"issue":"4","key":"2025090905070948700_luaf186-B3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10508-005-4338-5","article-title":"Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia","volume":"34","author":"Dessens","year":"2005","journal-title":"Arch Sex Behav"},{"issue":"2","key":"2025090905070948700_luaf186-B4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4158\/EP14351.RA","article-title":"Evidence supporting the biologic nature of gender identity","volume":"21","author":"Saraswat","year":"2015","journal-title":"Endocr Pract"},{"issue":"2","key":"2025090905070948700_luaf186-B5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ecl.2019.01.002","article-title":"Etiology of gender identity","volume":"48","author":"Korpaisarn","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"2025090905070948700_luaf186-B6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.fertnstert.2013.04.001","article-title":"Prevalence of polycystic ovary syndrome in adolescents","volume":"100","author":"Christensen","year":"2013","journal-title":"Fertil Steril"},{"key":"2025090905070948700_luaf186-B7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejogrb.2022.10.020","article-title":"Prevalence of polycystic ovary syndrome in European countries and USA: a systematic review and meta-analysis","volume":"279","author":"Chiaffarino","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"2025090905070948700_luaf186-B8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"issue":"1","key":"2025090905070948700_luaf186-B9","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primer"},{"issue":"4","key":"2025090905070948700_luaf186-B10","first-page":"529","article-title":"Polycystic ovary syndrome and gender identity","volume":"93","author":"Liu","year":"2020","journal-title":"Yale J Biol Med"},{"issue":"4","key":"2025090905070948700_luaf186-B11","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1210\/jc.2007-2808","article-title":"Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals","volume":"93","author":"Mueller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025090905070948700_luaf186-B12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jpag.2023.09.003","article-title":"Prevalence of polycystic ovarian syndrome in young and adolescent transmasculine patients presenting for gender-affirming care","volume":"37","author":"Rangi","year":"2024","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"10","key":"2025090905070948700_luaf186-B13","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025090905070948700_luaf186-B14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jpag.2020.06.017","article-title":"Perspectives on the international recommendations for the diagnosis and treatment of polycystic ovary syndrome in adolescence","volume":"33","author":"Rosenfield","year":"2020","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"2025090905070948700_luaf186-B15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2105\/AJPH.2016.303571","article-title":"Transgender demographics: a household probability sample of US adults, 2014","volume":"107","author":"Crissman","year":"2017","journal-title":"Am J Public Health"},{"issue":"8","key":"2025090905070948700_luaf186-B16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJMra021561","article-title":"Congenital adrenal hyperplasia","volume":"349","author":"Speiser","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"2025090905070948700_luaf186-B17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2265.1997.800904.x","article-title":"Mutations of the 5 alpha-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5 alpha-reductase-2 deficiency","volume":"46","author":"Canto","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"22","key":"2025090905070948700_luaf186-B18","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJM197905313002201","article-title":"Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5\u03b1-reductase deficiency","volume":"300","author":"Imperato-McGinley","year":"1979","journal-title":"N Engl J Med"},{"issue":"2","key":"2025090905070948700_luaf186-B19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/hbeh.2001.1684","article-title":"Androgens, androgen receptors, and male gender role behavior","volume":"40","author":"Wilson","year":"2001","journal-title":"Horm Behav"},{"issue":"5","key":"2025090905070948700_luaf186-B20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"issue":"2","key":"2025090905070948700_luaf186-B21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0015-0282(16)60060-2","article-title":"The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism","volume":"50","author":"Barbieri","year":"1988","journal-title":"Fertil Steril"},{"issue":"12","key":"2025090905070948700_luaf186-B22","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"2025090905070948700_luaf186-B23","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/humrep\/der291","article-title":"Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test","volume":"26","author":"Rosenfield","year":"2011","journal-title":"Hum Reprod"},{"key":"2025090905070948700_luaf186-B24","doi-asserted-by":"crossref","first-page":"bcr2014204797","DOI":"10.1136\/bcr-2014-204797","article-title":"Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours","volume":"2015","author":"Glintborg","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"4","key":"2025090905070948700_luaf186-B25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/humrep\/del474","article-title":"Association between polycystic ovary syndrome and female-to-male transsexuality","volume":"22","author":"Baba","year":"2007","journal-title":"Human Reprod"},{"issue":"1","key":"2025090905070948700_luaf186-B26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01542305","article-title":"Endocrine evaluation of forty female-to-male transsexuals: increased frequency of polycystic ovarian disease in female transsexualism","volume":"15","author":"Futterweit","year":"1986","journal-title":"Arch Sex Behav"},{"issue":"3","key":"2025090905070948700_luaf186-B27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","article-title":"Effects of cross-sex hormone treatment on transgender women and men","volume":"125","author":"Deutsch","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2025090905070948700_luaf186-B28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jadohealth.2020.03.028","article-title":"Physiological and metabolic characteristics of a cohort of transgender and gender-diverse youth in the United States","volume":"67","author":"Millington","year":"2020","journal-title":"J Adolesc Health"},{"issue":"1","key":"2025090905070948700_luaf186-B29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/camh.12437","article-title":"Review: puberty blockers for transgender and gender diverse youth\u2014a critical review of the literature","volume":"26","author":"Rew","year":"2021","journal-title":"Child Adolesc Ment Health"},{"issue":"2","key":"2025090905070948700_luaf186-B30","doi-asserted-by":"crossref","first-page":"e20191725","DOI":"10.1542\/peds.2019-1725","article-title":"Pubertal suppression for transgender youth and risk of suicidal ideation","volume":"145","author":"Turban","year":"2020","journal-title":"Pediatrics"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/10\/luaf186\/64226790\/luaf186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/10\/luaf186\/64226790\/luaf186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:07:18Z","timestamp":1757408838000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf186\/8249770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,8,19]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf186","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,8,19]]},"article-number":"luaf186"}}